HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
94.32
+1.66 (1.79%)
Sep 10, 2026, 12:29 PM EDT - Market open
HealthEquity Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, HealthEquity stock has a consensus rating of "Strong Buy" and an average price target of $119. The average 1-year stock price forecast is 26.17% higher than the current stock price, while the lowest is $105 (+11.32%) and the highest is $142 (+50.55%).
Price Target: $119 (+26.17%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HealthEquity stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 10 | 10 | 10 | 10 | 10 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Total | 16 | 16 | 16 | 16 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Reiterates $110 | Buy | Reiterates | $110 | +16.62% | Sep 9, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $125 | Buy | Reiterates | $125 | +32.53% | Sep 4, 2026 |
| Deutsche Bank | Deutsche Bank | Buy Reiterates $135 → $142 | Buy | Reiterates | $135 → $142 | +50.55% | Aug 31, 2026 |
| Barrington | Barrington | Buy Reiterates $110 | Buy | Reiterates | $110 | +16.62% | Aug 28, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $108 | Buy | Maintains | $108 | +14.50% | Aug 28, 2026 |
Financial Forecast
Revenue This Year
1.42B
from 1.31B
Increased by 7.85%
Revenue Next Year
1.53B
from 1.42B
Increased by 7.70%
EPS This Year
4.72
from 4.00
Increased by 18.09%
EPS Next Year
5.49
from 4.72
Increased by 16.31%
EPS and Forward PE are based on non-GAAP adjusted numbers.